Chargement en cours...
Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?
OBJECTIVE: Osteoporosis is one of the most common causes of vertebral compression fractures (VCFs). Teriparatide, a recombinant human parathyroid hormone, is the first anabolic agent for the treatment of osteoporosis. The aim of this study was to determine whether 3 months of teriparatide could be e...
Enregistré dans:
| Publié dans: | Korean J Neurotrauma |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Neurotraumatology Society
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495587/ https://ncbi.nlm.nih.gov/pubmed/31098345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.13004/kjnt.2019.15.e13 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|